Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Oct;34(10):1412–1417. doi: 10.1136/gut.34.10.1412

Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein.

S Tada 1, M Iida 1, T Yao 1, T Kitamoto 1, T Yao 1, M Fujishima 1
PMCID: PMC1374552  PMID: 8244111

Abstract

A clinicopathologic study was made of 16 patients with amyloidosis and with clinical signs of intestinal pseudo-obstruction. amyloid deposits in the small intestine were proved in all cases by endoscopic or intra-operative biopsies, and immunohistochemical study identified the chemical types of amyloid protein: amyloid A protein (AA) in 13 cases, light chain protein (AL) in two, and beta 2-microglobulin (AH) in one. Clinically, an acute self limiting obstructive condition was evident in 13 cases with AA, and 12 of them returned to normal bowel function after receiving total parenteral nutrition. Two cases with AL and one with AH presented chronic, intermittent, obstructive symptoms, and medical treatment, including total parenteral nutrition, was ineffective with no recovery of intestinal propulsion. Pathological examination of the necropsy specimens in seven cases showed considerable differences in the preferential sites of gastrointestinal deposits between the chemical types of amyloid; extensive infiltration and replacement of the muscularis propria by amyloid deposits throughout the gastrointestinal tract, especially the small intestine, were found in the AL and the AH cases, while amyloid deposits in the myenteric plexus without appreciable muscle infiltration were shown in the AA cases. These results show that intestinal pseudo-obstruction in patients with amyloidosis is caused by either myopathy or neuropathy, and that chemical types of amyloid may determine which of the two factors has the dominant affect on the bowel function.

Full text

PDF
1412

Images in this article

1413Figure 1
on p.1413
1413Figure 2
on p.1413
1414Figure 3
on p.1414
1415Figure 4
on p.1415
1415Figure 5
on p.1415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRODY I. A., WERTLAKE P. T., LASTER L. CAUSES OF INTESTINAL SYMPTOMS IN PRIMARY AMYLOIDOSIS. Arch Intern Med. 1964 Apr;113:512–518. doi: 10.1001/archinte.1964.00280100020004. [DOI] [PubMed] [Google Scholar]
  2. Battle W. M., Rubin M. R., Cohen S., Snape W. J., Jr Gastrointestinal-motility dysfunction in amyloidosis. N Engl J Med. 1979 Jul 5;301(1):24–25. doi: 10.1056/NEJM197907053010105. [DOI] [PubMed] [Google Scholar]
  3. Choi H. S., Heller D., Picken M. M., Sidhu G. S., Kahn T. Infarction of intestine with massive amyloid deposition in two patients on long-term hemodialysis. Gastroenterology. 1989 Jan;96(1):230–234. doi: 10.1016/0016-5085(89)90785-3. [DOI] [PubMed] [Google Scholar]
  4. Faulk D. L., Anuras S., Freeman J. B. Idiopathic chronic intestinal pseudo-obstruction. Use of central venous nutrition. JAMA. 1978 Nov 3;240(19):2075–2076. [PubMed] [Google Scholar]
  5. Fraser A. G., Arthur J. F., Hamilton I. Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride. Dig Dis Sci. 1991 Apr;36(4):532–535. doi: 10.1007/BF01298889. [DOI] [PubMed] [Google Scholar]
  6. Fuchs A., Jagirdar J., Schwartz I. S. Beta 2-microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis. A new type of amyloid. Am J Clin Pathol. 1987 Sep;88(3):302–307. doi: 10.1093/ajcp/88.3.302. [DOI] [PubMed] [Google Scholar]
  7. Gertz M. A., Kyle R. A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 1991 Jul;70(4):246–256. [PubMed] [Google Scholar]
  8. Gilat T., Revach M., Sohar E. Deposition of amyloid in the gastrointestinal tract. Gut. 1969 Feb;10(2):98–104. doi: 10.1136/gut.10.2.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gilat T., Spiro H. M. Amyloidosis and the gut. Am J Dig Dis. 1968 Jul;13(7):619–633. doi: 10.1007/BF02232969. [DOI] [PubMed] [Google Scholar]
  10. Glenner G. G. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med. 1980 Jun 5;302(23):1283–1292. doi: 10.1056/NEJM198006053022305. [DOI] [PubMed] [Google Scholar]
  11. Iida M., Yamamoto T., Yao T., Fuchigami T., Fujishima M. Jejunal endoscopy using a long duodenofiberscope. Gastrointest Endosc. 1986 Jun;32(3):233–236. doi: 10.1016/s0016-5107(86)71816-6. [DOI] [PubMed] [Google Scholar]
  12. Ikeda S. I., Makishita H., Oguchi K., Yanagisawa N., Nagata T. Gastrointestinal amyloid deposition in familial amyloid polyneuropathy. Neurology. 1982 Dec;32(12):1364–1368. doi: 10.1212/wnl.32.12.1364. [DOI] [PubMed] [Google Scholar]
  13. Kitamoto T., Ogomori K., Tateishi J., Prusiner S. B. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest. 1987 Aug;57(2):230–236. [PubMed] [Google Scholar]
  14. Krishnamurthy S., Schuffler M. D. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology. 1987 Sep;93(3):610–639. doi: 10.1016/0016-5085(87)90926-7. [DOI] [PubMed] [Google Scholar]
  15. Kyle R. A., Greipp P. R. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983 Oct;58(10):665–683. [PubMed] [Google Scholar]
  16. Legge D. A., Wollaeger E. E., Carlson H. C. Intestinal pseudo-obstruction in systemic amyloidosis. Gut. 1970 Sep;11(9):764–767. doi: 10.1136/gut.11.9.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Levin M., Franklin E. C., Frangione B., Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest. 1972 Oct;51(10):2773–2776. doi: 10.1172/JCI107098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Matsumoto T., Iida M., Hirakawa M., Hirakawa K., Kuroki F., Lee S., Nanbu T., Fujishima M. Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis. Dig Dis Sci. 1991 Dec;36(12):1756–1760. doi: 10.1007/BF01296621. [DOI] [PubMed] [Google Scholar]
  19. Ohyama T., Shimokama T., Yoshikawa Y., Watanabe T. Splenic amyloidosis: correlations between chemical types of amyloid protein and morphological features. Mod Pathol. 1990 Jul;3(4):419–422. [PubMed] [Google Scholar]
  20. Schuffler M. D., Rohrmann C. A., Chaffee R. G., Brand D. L., Delaney J. H., Young J. H. Chronic intestinal pseudo-obstruction. A report of 27 cases and review of the literature. Medicine (Baltimore) 1981 May;60(3):173–196. [PubMed] [Google Scholar]
  21. Shiiki H., Shimokama T., Yoshikawa Y., Toyoshima H., Kitamoto T., Watanabe T. Renal amyloidosis. Correlations between morphology, chemical types of amyloid protein and clinical features. Virchows Arch A Pathol Anat Histopathol. 1988;412(3):197–204. doi: 10.1007/BF00737143. [DOI] [PubMed] [Google Scholar]
  22. Tada S., Iida M., Iwashita A., Matsui T., Fuchigami T., Yamamoto T., Yao T., Fujishima M. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc. 1990 Jan-Feb;36(1):10–14. doi: 10.1016/s0016-5107(90)70913-3. [DOI] [PubMed] [Google Scholar]
  23. Wald A., Kichler J., Mendelow H. Amyloidosis and chronic intestinal pseudoobstruction. Dig Dis Sci. 1981 May;26(5):462–465. doi: 10.1007/BF01313592. [DOI] [PubMed] [Google Scholar]
  24. Wright J. R., Calkins E. Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) 1981 Nov;60(6):429–448. doi: 10.1097/00005792-198111000-00004. [DOI] [PubMed] [Google Scholar]
  25. Wright J. R., Calkins E., Humphrey R. L. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest. 1977 Mar;36(3):274–281. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES